Impact of thrombolysis on stroke outcome at 12 months in a population: The bern stroke project

Stroke

Volumn 43, Issue 4, 2012, Pages 1039-1045

  Fischer, Urs ^a   Mono, Marie Luise ^a   Zwahlen, Marcel ^b   Nedeltchev, Krassen ^a   Arnold, Marcel ^a   Galimanis, Aekatarini ^a   Bucher, Sabine ^b   Findling, Oliver ^a   Meier, Niklaus ^a   Brekenfeld, Caspar ^a,b   Gralla, Jan ^a,b   Heller, Regula ^c   Tschannen, Beatrice ^d   Schaad, Heinz ^e   Waldegg, Gabriel ^e   Zehnder, Thomas ^e   Ronsdorf, Anke ^e   Oswald, Phillip ^e   Brunner, Georg ^e   Schroth, Gerhard ^a,b   Mattle, Heinrich P ^a   more..

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Verein Outcome   (Switzerland)

^d Canton of Bern   (Switzerland)

^e Regionalspital Emmental Burgdorf ^*  (Switzerland)

Author keywords

acute ischemic stroke; long term outcome; thrombolysis

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ACUTE DISEASE; ACUTE ISCHEMIC STROKE; ADULT; AGED; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN ISCHEMIA; CHARLSON COMORBIDITY INDEX; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MORTALITY; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; SMOKING; SWITZERLAND;

AGE FACTORS; AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE; SURVIVAL RATE; SWITZERLAND; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 84859429492     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.630384     Document Type: Article

References (29)

1. The National Institute of Neurological Disorders and Stroke rt-PA, Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med.1995;333:1581-1588
2. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al., for the PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study: A randomized controlled trial. JAMA.1999;282:2003-2011
3. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, et al. for the SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet. 2007; 369:275-282 (Pubitemid 46138121)
4. Nedeltchev K, Fischer U, Arnold M, Ballinari P, Haefeli T, Kappeler L, et al. Long-term effect of intra-arterial thrombolysis in stroke. Stroke. 2006;37:3002-3007 (Pubitemid 44900822)
5. Schmulling S, Grond M, Rudolf J, Heiss WD. One-year follow-up in acute stroke patients treated with rtPA in clinical routine. Stroke. 2000; 31:1552-1554 (Pubitemid 30437502)
6. Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med. 1999;340:1781-1787
7. Thomassen L, Waje-Andreassen U, Naess H, Elvik MK, Russell D. Long-term effect of intravenous thrombolytic therapy in acute stroke: Responder analysis versus uniform analysis of excellent outcome. Cerebrovasc Dis. 2005;20:470-474 (Pubitemid 41675026)
8. Hatano S. Experience from a multicentre stroke register: A preliminary report. Bull World Health Organ. 1976;54:541-553 (Pubitemid 8114220)
9. Fischer U, Arnold M, Nedeltchev K, Schoenenberger RA, Kappeler L, Hoellinger P, et al. Impact of comorbidity on ischemic stroke outcome. Acta Neurol Scand. 2006;113:108-113
10. Brott T, Adams HP Jr., Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: A clinical examination scale. Stroke. 1989;20:846-870
11. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41 (Pubitemid 23014379)
12. Adams H, Adams R, Del Zoppo G, Goldstein LB, Stroke Council of the American Heart Association, American Stroke Association. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke. 2005; 36:916-923
13. Arnold M, Schroth G, Nedeltchev K, Loher T, Remonda L, Stepper F, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke. 2002;33:1828-1833 (Pubitemid 34761070)
14. European Stroke Initiative recommendations for stroke management. European Stroke Council, European Neurological Society and European Federation of Neurological Societies. Cerebrovasc Dis. 2000;10: 335-351
15. European Stroke Initiative Executive Committee, EUSI Writing Committee, Olsen TS, Langhorne P, Diener HC, Hennerici M, et al.European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis. 2003;16:311-337 (Pubitemid 37142462)
16. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607
17. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemol. 2004;159:702-706 (Pubitemid 38405384)
18. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;115:550-560 (Pubitemid 30660034)
19. Hill MD, Buchan AM, Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005; 172:1307-1312 (Pubitemid 40745072)
20. Jørgensen HS, Nakayama H, Kammersgaard LP, Raaschou HO, Olsen TS. Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients: simulation model. BMJ. 1999;319: 288-289 (Pubitemid 29353940)
21. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004; 363:768-774
22. van Wijngaarden JD, Dirks M, Huijsman R, Niessen LW, Fabbricotti IN, Dippel DW, et al. Hospital rates of thrombolysis for acute ischemic stroke: the influence of organizational culture. Stroke. 2009;40: 3390-3392
23. Gladstone DJ, Rodan LH, Sahlas DJ, Lee L, Murray BJ, Ween JE, et al. A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke. 2009;40:3841-3844
24. Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke. 2003;34:1106-1113
25. Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: A systematic review. Stroke. 2009;40:1082-1090
26. Roquer J, Campello AR, Gomis M. Sex differences in first-ever acute stroke. Stroke. 2003;34:1581-1585 (Pubitemid 36842605)
27. Gostynski M, Engelter S, Papa S, Ajdacic-Gross V, Gutzwiler F, Lyrer P. Incidence of first-ever ischemic stroke in the Canton of Basle-City, Switzerland. A population-based study 2002/2003. J Neurol. 2005; 86-91 (Pubitemid 43157393)
28. Mattle HP, Eicher Vella E, Bassetti C, Sandercock P. International Stroke Trial Switzerland: some epidemiologic data. Schweiz Med Wochenschr. 1999;129:1964-1969 (Pubitemid 30012957)
29. Sudlow CL, Warlow CP. Comparing stroke incidence worldwide: what makes studies comparable? Stroke. 1996;27:550-558.